Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for melanoma, cutaneous malignant, susceptibility to, 5 has been reported in the published literature.
No clinical trials have been registered for melanoma, cutaneous malignant, susceptibility to, 5.
130 publications have been identified in PubMed for melanoma, cutaneous malignant, susceptibility to, 5. Research spans Epidemiology / Natural History (31%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 40 | 31% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:02 AM UTC
Online Mendelian Inheritance in Man
Research summaries |
33 |
25% |
Testing and diagnosis research | 19 | 15% |
Laboratory research | 18 | 14% |
Clinical study results | 9 | 7% |
Patient case studies | 8 | 6% |
Other research | 2 | 2% |
New treatment approaches | 1 | 1% |
Mancini S (2026). [PMID: 41513596](https://pubmed.ncbi.nlm.nih.gov/41513596/). *Cancer Med*. [Epidemiology / Natural History]
Johansson PA (2026). [PMID: 41673532](https://pubmed.ncbi.nlm.nih.gov/41673532/). *Pigment Cell Melanoma Res*. [Epidemiology / Natural History]
Siddiqui FS (2026). [PMID: 40811605](https://pubmed.ncbi.nlm.nih.gov/40811605/). *Unknown Journal*. [Epidemiology / Natural History]
Nelson M MD, FAAFP (2026). [PMID: 42166765](https://pubmed.ncbi.nlm.nih.gov/42166765/). *FP Essent*. [Review / Meta-Analysis]
Geidel G (2026). [PMID: 41932032](https://pubmed.ncbi.nlm.nih.gov/41932032/). *Eur J Cancer*. [Other]
Landi MT (2026). [PMID: 42183343](https://pubmed.ncbi.nlm.nih.gov/42183343/). *Res Sq*. [Basic Science / Preclinical]
Bristow IR (2026). [PMID: 42165691](https://pubmed.ncbi.nlm.nih.gov/42165691/). *J Foot Ankle Res*. [Review / Meta-Analysis]
Wang Y (2026). [PMID: 41804614](https://pubmed.ncbi.nlm.nih.gov/41804614/). *Expert Rev Anticancer Ther*. [Diagnostic / Biomarker]
Rutland CD (2026). [PMID: 41725031](https://pubmed.ncbi.nlm.nih.gov/41725031/). *Appl Immunohistochem Mol Morphol*. [Basic Science / Preclinical]
D'Onghia M (2026). [PMID: 41828014](https://pubmed.ncbi.nlm.nih.gov/41828014/). *Diagnostics (Basel)*. [Review / Meta-Analysis]